Targeting Parkinson's Disease 2013
June 4 - 6, 2013
Philadelphia PA , USA
The Targeting Parkinson’s Disease symposium will address both disease modification and therapeutic development for levodopa induced dyskinesia, an unmet medical need within Parkinson’s treatment, and other PD-treatment symptoms. Advances in target identification, biomarker development, and genetics (such as LRKK2 and alpha-synuclein) will also be discussed.
Related events
Targeting Parkinson's Disease June 4 - 6, 2015
Targeting Parkinson's Disease June 4 - 6, 2014
Targeting Parkinson's Disease June 4 - 6, 2013
Targeting Parkinson's Disease 4 June, 2012
Targeting Parkinson's Disease June 8 - 9, 2011
